Europe Point of Care Ultrasound (PoCUS) Device Market Overview

The Europe point of care ultrasound (pocus) device market which was valued at approximately USD 310.43 million in 2025 and is estimated to rise further up to almost USD 331.19 million by 2026, is projected to reach around USD 593.20 million in 2035, expanding at a CAGR of about 6.69% during the forecast period from 2026 to 2035.

Market expansion is driven by increasing demand for rapid bedside diagnostics, rising clinical reliance on portable imaging technologies, and growing use of ultrasound guided procedures across acute and primary care. Reports published by the World Health Organization emphasize the role of point of care diagnostics in improving early detection and reducing diagnostic delays, supporting wider clinical adoption across European healthcare systems.

Government backed initiatives aimed at strengthening diagnostic capacity and improving emergency care access are further supporting market expansion across Europe. Policy frameworks from the European Commission focusing on healthcare system resilience and medical technology modernization encourage adoption of decentralized imaging solutions. In addition, health system performance assessments published by the Organization for Economic Cooperation and Development highlight the importance of efficient diagnostic workflows in reducing hospital burden. National public health authorities and institutions such as the European Centre for Disease Prevention and Control promote early diagnosis and point of care testing, reinforcing demand across key markets including Germany, France, and the United Kingdom, while other European countries account for the remaining regional contribution.

Europe Point of Care Ultrasound (PoCUS) Device Market Dynamics

Market Trends

The industry landscape is experiencing a clear shift toward compact, software driven, and workflow integrated imaging solutions, aligned with evolving clinical practices and public health priorities. One of the key trends shaping the market is the growing preference for handheld and portable ultrasound systems, reflecting demand for rapid diagnostics, operational efficiency, and reduced dependency on centralized radiology units. Another emerging trend is the integration of artificial intelligence enabled image enhancement and decision support tools, driven by digital health strategies promoted by the European Commission and national health ministries. Policy guidance from the World Health Organization and digital health frameworks supported by European public health authorities emphasizes early diagnosis, point of care decision making, and interoperability, encouraging manufacturers to focus on advanced visualization, cloud connectivity, and clinician friendly system design.

Growth Drivers

Market growth is primarily supported by the rising burden of chronic diseases and emergency care demand, which continues to generate consistent adoption across hospitals, ambulatory centers, and primary care settings. Public investment in healthcare infrastructure modernization, supported by funding programs under European Union health resilience initiatives, is accelerating deployment of decentralized diagnostic technologies. In addition, guidance from the World Health Organization and the Organization for Economic Cooperation and Development highlights the importance of timely diagnostics in reducing treatment delays and healthcare costs. As clinicians prioritize efficiency, accuracy, and bedside accessibility, demand for point of care imaging solutions remains strong, particularly in emergency medicine, critical care, and internal medicine, reinforcing sustained expansion across major European healthcare systems.

Market Restraints / Challenges

Despite favorable growth conditions, the market faces challenges related to regulatory complexity and cost sensitivity. Compliance with stringent medical device regulations under European Union frameworks, including conformity assessment and post market surveillance requirements, increases development timelines and operational costs for manufacturers. Reports from the European Commission on medical device implementation indicate that smaller healthcare facilities may face barriers to adoption due to budget limitations and training requirements. In addition, dependence on skilled operators and advanced software capabilities can create operational constraints, particularly in under resourced settings. These factors may affect penetration rates among smaller clinics and rural healthcare providers, influencing overall market performance during periods of fiscal pressure.

Market Opportunities

The market presents significant opportunities in expanding access to portable and cost optimized ultrasound systems, particularly in community healthcare, home care, and outpatient diagnostics. Demographic shifts toward aging populations, combined with rising prevalence of cardiovascular and respiratory conditions, are creating unmet demand for frequent and noninvasive imaging. Public health strategies supported by the World Health Organization and national healthcare agencies emphasize early intervention and primary care strengthening, opening avenues for wider pocus adoption. Additional opportunities lie in advanced digital integration, including artificial intelligence assisted diagnostics and remote consultation capabilities. Companies offering scalable, software enhanced, and clinically versatile solutions are well positioned to build long term partnerships with healthcare providers and capture incremental demand across Europe.

Europe Point of Care Ultrasound (PoCUS) Device Market Report Coverage

Report Metric	Details
Historical Period	2020 - 2024
Base Year Considered	2025
Forecast Period	2026 - 2035
Market Size in 2025	U.S.D.  331.19 Million
Revenue Forecast in 2035	U.S.D.  593.2 Million
Growth Rate	6.69%
Segments Covered in the Report	By Type, By Portability, By Application, By End User
Report Scope	Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling
Regions Covered in the Report	Germany, United Kingdom, France, Rest of Europe

Europe Point of Care Ultrasound (PoCUS) Device Market Segmentation

By Type

Diagnostic pocus devices accounted for the largest revenue share in 2025, representing approximately 68% of total market value, supported by their widespread use in emergency medicine, critical care, cardiology, and primary care diagnostics. High utilization frequency, broader clinical applicability, and integration into routine bedside assessments continue to reinforce demand for diagnostic systems across European hospitals and outpatient facilities. Guidance issued by public health authorities and clinical societies emphasizes early detection and rapid decision making, further strengthening adoption in acute and non-acute care settings. Consistent investments in diagnostic infrastructure modernization across Europe also contribute to sustained dominance of this segment.

Therapeutic pocus devices are expected to register faster growth, with an estimated CAGR of 8.6% during the forecast period. Growth is driven by increasing use of ultrasound guided interventions, pain management procedures, and minimally invasive therapies. Government supported initiatives promoting image guided clinical workflows and patient safety improvements encourage wider clinical acceptance. Expansion of training programs for ultrasound guided procedures and rising adoption in specialty clinics further support growth, positioning therapeutic systems as an increasingly important contributor to overall market expansion.

By Portability

Cart based pocus devices held the largest share in 2025, contributing approximately 57% of segment revenue, due to their higher imaging capabilities, advanced software integration, and established use in hospital departments such as intensive care units and emergency rooms. These systems benefit from longer operational lifecycles and compatibility with multiple clinical applications, supporting steady procurement by large healthcare facilities. Public sector investments in hospital infrastructure and diagnostic capacity expansion across Europe continue to sustain demand for cart-based platforms.

Compact and handheld pocus devices are projected to witness the fastest growth, registering an estimated CAGR of 9.1% from 2026 to 2035. Growth is supported by increasing demand for mobility, rapid bedside assessment, and deployment in ambulatory and community care settings. Digital health strategies promoted by European public health institutions emphasize decentralization of diagnostics and improved access, accelerating adoption of portable systems. Advancements in battery performance, wireless connectivity, and cloud-based data integration further enhance clinical utility, reinforcing strong growth momentum.

By Application

Emergency medicine accounted for the largest share in 2025, representing approximately 29% of application-level revenue, supported by the critical need for rapid diagnostic decision making in trauma and acute care scenarios. Clinical protocols endorsed by public health authorities emphasize pocus as a first line imaging tool in emergency settings, reinforcing consistent demand across European healthcare systems.

Intensive care applications are expected to grow at a CAGR of around 8.4%, driven by increasing utilization for hemodynamic monitoring, lung assessment, and procedural guidance. Rising prevalence of chronic and respiratory conditions and government backed investments in critical care preparedness contribute to sustained adoption. Cardiology focused pocus applications are also expanding steadily, supported by aging populations and increasing burden of cardiovascular disease.

Other applications, including obstetrics and gynecology, musculoskeletal, vascular and urology, anesthesia related imaging, and general medicine, collectively are projected to grow at an average CAGR of approximately 7.6%. Growth across these areas is supported by expanding clinical training, broader scope of ultrasound guided procedures, and integration of pocus into routine patient assessment pathways.

By End User

Based on end user, hospitals accounted for the largest share of the market in 2025, contributing approximately 61% of total revenue. Their dominance is supported by high patient volumes, advanced diagnostic infrastructure, and centralized procurement of imaging technologies. Government funded healthcare systems across Europe continue to prioritize hospital based diagnostic capabilities, supported by national health budgets and public investment programs. The concentration of skilled professionals and availability of multidisciplinary care further reinforce hospital dominance in pocus adoption.

Clinics and ambulatory care centers are expected to register faster growth, with an estimated CAGR of 8.3% during the forecast period. Expansion of outpatient services, rising preference for same day diagnostics, and policy initiatives aimed at reducing hospital burden are driving adoption in these settings.

Other end users, including ambulatory surgical centers and specialized care facilities, are projected to grow at a CAGR of approximately 7.5%, supported by procedural volume growth and increasing use of ultrasound guided interventions across decentralized healthcare environments.

Regional Insights

Germany

Germany accounted for approximately 28% of the Europe point of care ultrasound (pocus) device market in 2025, supported by high healthcare expenditure, advanced hospital infrastructure, and strong adoption of diagnostic imaging technologies across acute and primary care settings. Major medical hubs such as Berlin, Munich, and Hamburg continue to drive demand due to high patient throughput and concentration of tertiary care hospitals. Policy guidance and health system reports issued by the Federal Ministry of Health emphasize early diagnosis and efficiency in emergency and critical care, reinforcing pocus integration. Public reimbursement structures and investments under national digital health strategies further support procurement of portable and cart-based ultrasound systems, strengthening Germany’s leading position in the regional landscape.

United Kingdom

The United Kingdom represents approximately 19% of the regional market in 2025, driven by widespread adoption of pocus within emergency medicine, general practice, and ambulance services. Strong demand from urban healthcare networks in London, Manchester, and Birmingham supports steady market growth. Clinical guidelines and workforce training programs promoted by the National Health Service encourage the use of point of care imaging to reduce diagnostic delays and hospital congestion. Government backed investments in frontline diagnostics and digital health transformation initiatives further stimulate adoption of handheld and mobile ultrasound devices across hospitals and community care settings, contributing to sustained expansion of the market.

France

France accounted for an estimated 16% of the Europe pocus device market in 2025, supported by structured healthcare delivery systems and increasing use of ultrasound in emergency and intensive care environments. High adoption rates are observed in major cities including Paris, Lyon, and Marseille, where hospitals prioritize rapid bedside diagnostics. National health strategies published by the Ministry of Solidarity and Health promote modernization of diagnostic infrastructure and improved access to imaging technologies. Public funding for hospital equipment upgrades and professional training initiatives enhances clinician proficiency, supporting steady uptake of point of care ultrasound across both public and private healthcare facilities.

Rest of Europe

Other European countries, including Italy, Spain, the Nordic countries, and others, collectively account for approximately 14% of the market in 2025. Growth in these markets is supported by healthcare modernization programs, rising emphasis on early diagnosis, and gradual expansion of pocus training among clinicians. Reports from European public health institutions highlight the role of decentralized diagnostics in improving care efficiency and reducing system burden across smaller and developing European healthcare systems with long-term growth potential, contributing to the remaining market share.

Competitive Landscape / Company Insights

The Europe point of care ultrasound (pocus) device market is moderately to highly competitive, with a mix of multinational and regional manufacturers emphasizing product innovation, pricing optimization, and geographic expansion. Companies are increasingly investing in research and development, software enabled imaging, and artificial intelligence integration to enhance clinical efficiency. Adoption is supported by public healthcare modernization initiatives promoted by the European Commission, clinical guidance from the World Health Organization, and national health system investment programs that prioritize early diagnosis, decentralized imaging, and improved emergency care delivery across Europe.

Mini Profiles

Alpinion Medical Systems Co., Ltd. focuses on advanced ultrasound imaging solutions, supported by strong R&D capabilities, expanding global distribution networks, and competitive pricing that strengthens adoption across hospital and point-of-care settings.

Canon Medical Systems Corporation operates in premium diagnostic imaging segments, emphasizing high-resolution ultrasound performance, workflow optimization, and reliability, supported by strong brand recognition and long-standing relationships with healthcare institutions.

Esaote S.p.A. leverages specialized ultrasound expertise and strategic partnerships to expand market presence, offering compact and application-focused PoCUS systems supported by localized manufacturing and strong penetration across European healthcare markets.

FUJIFILM Sonosite, Inc. focuses on point-of-care ultrasound systems, supported by clinician-centric design, robust training programs, and strong adoption across emergency, critical care, and bedside diagnostic applications globally.

GE HealthCare Technologies, Inc. operates across premium and mass ultrasound segments, emphasizing technological innovation, AI-enabled imaging, and integrated digital platforms, supported by extensive service networks and government-backed healthcare collaborations.

Key Players

• Alpinion Medical Systems Co., Ltd.
• Canon Medical Systems Corporation
• Esaote S.p.A.
• FUJIFILM Sonosite, Inc.
• GE HealthCare Technologies, Inc.
• Hitachi Ltd.
• Koninklijke Philips N.V.
• Samsung Medison Co., Ltd.
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Siemens Healthineers AG

Recent Developments

In February 2026, ReadyFixTM, a remote fleet management solution created to assist healthcare systems in supporting device uptime, was launched in the United States by GE HealthCare. The MAC VU360TM resting ECG workstations from GE HealthCare, which are made to provide high-quality ECG readings that enable physicians to make quicker, more assured decisions about cardiac care, will easily connect with ReadyFix. In order to promote optimal MAC VU360 performance and cardiac care continuity, healthcare systems can use real-time** data for remote device diagnostics and repair when linked with ReadyFix.

In November 2025, A new AI-powered feature called PIV Assist was introduced by FUJIFILM Sonosite, Inc., a world leader in point-of-care ultrasound (POCUS) technologies, to help physicians plan peripheral intravenous (PIV) access procedures. Sonosite LX, Sonosite PX, and Sonosite ST ultrasound systems will be able to use the feature.

In August 2025, Epica International, a world leader in cutting-edge CT and imaging technologies, has partnered with Esaote North America, Inc., a market leader in specialized MRI, ultrasound, and healthcare IT solutions. In order to increase market presence and hasten the adoption of high-performance MRI and CT technologies in the human and veterinary healthcare sectors, this partnership brings together two complementary portfolios. With the help of Epica International's ground-breaking CT imaging solutions, Esaote North America is able to expand its presence in the imaging sector by providing a wide range of MRI and ultrasound systems for humans and animals.